Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Makers Urge Caution In Thai Review Of Compulsory License Policy

This article was originally published in PharmAsia News

Executive Summary

Drug makers are urging Thailand's new government to proceed with caution in deciding whether to keep a compulsory license policy for drugs. The Thai Chamber of Commerce fears that if the CL policy continues, the country could end up on the U.S. list of countries denied favorable trade treatment. The urging coincided with the new prime minister's instructions to the ministries of Public Health, Commerce and Foreign to consider the matter. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067649

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel